fear of cancer recurrence in breast, colorectal and prostate cancer survivors.
Conditions
Interventions
The intervention is designed as blended care, combining traditional face-to-face cognitive behavior therapy (CBT) with online activities (psycho-education, assignments, assessments and therapist conta
Sponsors
Radboud University Medical Center
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically proven breast, colorectal or prostate cancer. 2. Primary curative-intent cancer treatment is completed between six months and five years ago. 3. Patients are disease-free at moment of study inclusion, as defined by the absence of somatic disease activity parameters;. 4. Patients are at least 18 years of age at time of inclusion (therefore defined as ‘adult’ by Dutch law); 5. Cancer Worry Scale score of 14 or higher, indicating a high level of fear of cancer recurrence. 6. Have sufficient Dutch language skills to complete questionnaires and engage in active conversation. 7. Patients are able to travel to hospital for CBT. 8. Are willing and able to give written informed consent according to legal requirements.
Exclusion criteria
Exclusion criteria: 1. Primary curative-intent cancer treatment is completed less than 6 months ago. 2. Currently receiving psychological or psychiatric therapy for psychiatric co morbidity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fear of cancer recurrence as measured with the cancer worry scale (CWS). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Disease specific quality of life (EORTC-QLQ-C30), supplemented by a disease specific module: BR23 for breast cancer, CR29 for colorectal cancer or PR25 for prostate cancer. 2. Satisfaction with Life (Satisfaction With Life – Scale) | — |
Contacts
Public ContactM.A. Wal, van der
Radboud UMC
Outcome results
None listed